{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:54:45Z","timestamp":1791237285169,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003382","name":"Core Research for Evolutional Science and Technology","doi-asserted-by":"publisher","award":["JP25gm1610007"],"award-info":[{"award-number":["JP25gm1610007"]}],"id":[{"id":"10.13039\/501100003382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H05465"],"award-info":[{"award-number":["JP23H05465"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23K06901"],"award-info":[{"award-number":["JP23K06901"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25K01957"],"award-info":[{"award-number":["JP25K01957"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrep.2026.102676","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T11:37:48Z","timestamp":1781782668000},"page":"102676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A novel corneal epithelial cell culture assay for assessing topical antivirals against herpes simplex virus keratitis"],"prefix":"10.1016","volume":"47","author":[{"given":"Hidenobu","family":"Kuniyoshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Sasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5892-0040","authenticated-orcid":false,"given":"Hironori","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0237-4746","authenticated-orcid":false,"given":"Nobuo","family":"Fuse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"Sarafianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-2752","authenticated-orcid":false,"given":"Eiichi N.","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2026.102676_bib1","article-title":"Global research trend of Herpes simplex keratitis: a bibliometric analysis and visualization from 1941 to 2024","volume":"12","author":"Song","year":"2025","journal-title":"Front. Med."},{"issue":"Suppl 1","key":"10.1016\/j.bbrep.2026.102676_bib2","doi-asserted-by":"crossref","first-page":"S244","DOI":"10.1097\/ICL.0000000000000393","article-title":"AmpliVue is a practical and timely test for the detection of HSV from keratitis specimens","volume":"44","author":"Kowalski","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.bbrep.2026.102676_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/02713683.2021.2009518","article-title":"Herpes Simplex Virus 2 Blepharokeratoconjunctivitis","volume":"47","author":"Yadav","year":"2022","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbrep.2026.102676_bib4","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.survophthal.2012.01.005","article-title":"Herpes simplex epithelial and stromal keratitis: an epidemiologic update","volume":"57","author":"Farooq","year":"2012","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.bbrep.2026.102676_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/09286586.2021.1962919","article-title":"Incidence of Herpes simplex virus keratitis and other ocular disease: global review and estimates","volume":"29","author":"McCormick","year":"2022","journal-title":"Ophthalmic Epidemiol."},{"key":"10.1016\/j.bbrep.2026.102676_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics12102368","article-title":"Clinical management of Herpes simplex virus keratitis","volume":"12","author":"Labib","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/j.bbrep.2026.102676_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed7060092","article-title":"Incidence and risk factors of bilateral herpetic Keratitis: 2022 update","volume":"7","author":"Chaloulis","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.bbrep.2026.102676_bib8","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/bjo.80.2.140","article-title":"Randomised trial of ganciclovir and acyclovir in the treatment of herpes simplex dendritic keratitis: a multicentre study","volume":"80","author":"Hoh","year":"1996","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrep.2026.102676_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/v15061314","article-title":"A narrative review of alternative symptomatic treatments for Herpes Simplex virus","volume":"15","author":"Chang","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbrep.2026.102676_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0166-0934(91)90008-N","article-title":"An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds","volume":"33","author":"Takeuchi","year":"1991","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bbrep.2026.102676_bib11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0166-0934(94)90041-8","article-title":"A sensitive assay system screening antiviral compounds against herpes simplex virus type 1 and type 2","volume":"49","author":"Sudo","year":"1994","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.bbrep.2026.102676_bib12","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/bjo.69.11.847","article-title":"Randomised double-blind trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex amoeboid corneal ulceration","volume":"69","author":"Collum","year":"1985","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrep.2026.102676_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/bjo.66.6.361","article-title":"A randomised double-blind clinical trial of acyclovir (Zovirax) and adenine arabinoside in herpes simplex corneal ulceration","volume":"66","author":"Young","year":"1982","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.bbrep.2026.102676_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/02713688609015124","article-title":"Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues","volume":"5","author":"O'Brien","year":"1986","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbrep.2026.102676_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1013162","article-title":"Herpes simplex virus type-1 infection and spread in a novel porcine corneal explant model is restricted to the epithelium","volume":"21","author":"Arshad","year":"2025","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrep.2026.102676_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010688","article-title":"Swarms of chemically modified antiviral siRNA targeting herpes simplex virus infection in human corneal epithelial cells","volume":"18","author":"Kalke","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bbrep.2026.102676_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/095632029901000404","article-title":"Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro","volume":"10","author":"Shigeta","year":"1999","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bbrep.2026.102676_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.exer.2006.11.014","article-title":"Establishment of a corneal epithelial cell line spontaneously derived from human limbal cells","volume":"84","author":"Liu","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.bbrep.2026.102676_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2023.02.005","article-title":"Establishing an accurate and sensitive in vitro drug screening system for human adenovirus infection with human corneal cells","volume":"581","author":"Sasano","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.bbrep.2026.102676_bib20","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1348-0421.1996.tb01080.x","article-title":"Evaluation of antiherpetic compounds using a gastric cancer cell line: pronounced activity of BVDU against herpes simplex virus replication","volume":"40","author":"Kodama","year":"1996","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.bbrep.2026.102676_bib21","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/AAC.45.5.1539-1546.2001","article-title":"4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitro","volume":"45","author":"Kodama","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrep.2026.102676_bib22","doi-asserted-by":"crossref","DOI":"10.1177\/2040206620921319","article-title":"Application of human lymphoid cells for the evaluation of antivirals against human adenovirus type 19: zalcitabine has superior activity compared to cidofovir","volume":"28","author":"Nakagawara","year":"2020","journal-title":"Antivir. Chem. Chemother."},{"key":"10.1016\/j.bbrep.2026.102676_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0006-2952(99)00325-1","article-title":"Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells","volume":"59","author":"Kodama","year":"2000","journal-title":"Biochem. Pharmacol."},{"issue":"Suppl A","key":"10.1016\/j.bbrep.2026.102676_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/jac\/14.suppl_A.85","article-title":"The antiviral spectrum of (E)-5-(2-bromovinyl)-2'-deoxyuridine","volume":"14","author":"De Clercq","year":"1984","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.bbrep.2026.102676_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128405","article-title":"Synthesis and antiviral effect of phosphamide modified vidarabine for treating HSV 1 infections","volume":"52","author":"Wang","year":"2021","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.bbrep.2026.102676_bib26","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0002-9343(82)90106-1","article-title":"Acyclovir and vidarabine for the treatment of herpes simplex keratitis","volume":"73","author":"Laibson","year":"1982","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrep.2026.102676_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/AAC.22.3.499","article-title":"Effect of combinations of acyclovir with vidarabine or its 5'-monophosphate on herpes simplex viruses in cell culture and in mice","volume":"22","author":"Schinazi","year":"1982","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbrep.2026.102676_bib28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0166-3542(82)90024-9","article-title":"Anti-herpesvirus activity of adenine arabinoside analogues in tissue culture and a genital infection of mice and Guinea pigs","volume":"2","author":"Richards","year":"1982","journal-title":"Antivir. Res."},{"key":"10.1016\/j.bbrep.2026.102676_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104421","article-title":"Challenges of aciclovir-resistant HSV infection in allogeneic bone marrow transplant recipients","volume":"128","author":"Anton-Vazquez","year":"2020","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.bbrep.2026.102676_bib30","doi-asserted-by":"crossref","first-page":"247","DOI":"10.36518\/2689-0216.1301","article-title":"Acyclovir-resistant anogenital Herpes simplex virus in an HIV patient with pseudoepitheliomatous hyperplasia resembling squamous cell carcinoma","volume":"3","author":"Charles","year":"2022","journal-title":"HCA Healthc J Med"},{"key":"10.1016\/j.bbrep.2026.102676_bib31","doi-asserted-by":"crossref","first-page":"25348","DOI":"10.1074\/jbc.M302055200","article-title":"Identification of a human valacyclovirase: biphenyl hydrolase-like protein as valacyclovir hydrolase","volume":"278","author":"Kim","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2026.102676_bib32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1006\/bbrc.1998.9298","article-title":"Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir","volume":"250","author":"Balimane","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrep.2026.102676_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7","article-title":"Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2","volume":"89","author":"Sugawara","year":"2000","journal-title":"J. Pharmaceut. Sci."},{"key":"10.1016\/j.bbrep.2026.102676_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1076\/ceyr.26.3.151.14893","article-title":"Novel dipeptide prodrugs of acyclovir for ocular herpes infections: bioreversion, antiviral activity and transport across rabbit cornea","volume":"26","author":"Anand","year":"2003","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.bbrep.2026.102676_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105705","article-title":"The new paradigm in animal testing - \"3Rs alternatives\"","volume":"153","author":"Poh","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580826002360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:08:32Z","timestamp":1791234512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580826002360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S2405580826002360"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102676","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel corneal epithelial cell culture assay for assessing topical antivirals against herpes simplex virus keratitis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2026.102676","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102676"}}